This webinar describes the cellular immune landscape that occurs following Ebola virus infection and will correlate these findings with key features of Ebola virus disease. Attendees will learn about Ebola virus induced T cell activation, B cell expansion and monocyte redistribution as well as alterations in dendritic cells that could be clues as to why Ebola virus disease is so severe.
Dr. McElroy is a pediatric infectious disease physician with a research interest in hemorrhagic fever viruses. She holds an appointment as an Assistant Professor in the School of Medicine at the University of Pittsburgh. She is a member of the University of Pittsburgh Center for Vaccine Research. She provides clinical care at UPMC Children's Hospital of Pittsburgh. Her lab focuses on the mechanisms by which hemorrhagic fever viruses cause disease.
Clive Gray is Professor of Immunology and Chair, Division of Immunology in the Institute of Infectious Disease and Molecular Medicine, University of Cape Town. He is also visiting professor in the Department of Immunology, Duke University. He is vice-chair of the IUIS Education Committee and Secretary General of the Federation of African Immunology Societies. He has worked in HIV immunology for over twenty years and is passionate about building immunology capacity in Africa. He is director of the Immunopaedia Foundation and runs the award winning on-line immunology education and teaching immunopaedia platform. He has trained in excess of 500 students around Africa over the past 10 years.
At Fluidigm, we empower our customers to reveal meaningful insights in health and disease, identify actionable markers to inform life decisions and accelerate the development of more effective therapies.
We focus on the most pressing needs in translational and clinical research, including cancer, immunology and immunotherapy. Harnessing proprietary CyTOF® and microfluidics capabilities, we provide an unprecedented view into health and disease through our unique combination of innovative mass cytometry, tissue imaging and genomics solutions.
As a trusted partner of leading academic, government, pharmaceutical, biotechnology and plant and animal research laboratories worldwide, we strive to increase the quality of life for all.